Several revolutionary therapies are now accessible in the UK for treating diabetes type 2 . Saxenda, Rybelsus , and Jardiance represent different approaches, with Saxenda and Trulicity being injectable incretin receptor activators primarily aimed at weight management alongside glucose control , w